| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,470 |
5,106 |
$163K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,615 |
5,284 |
$156K |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
2,486 |
2,017 |
$43K |
| 99215 |
Prolong outpt/office vis |
1,124 |
844 |
$21K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,271 |
1,758 |
$16K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,070 |
1,654 |
$10K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
488 |
176 |
$4K |
| 80305 |
|
2,600 |
1,995 |
$3K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
378 |
340 |
$2K |
| G0179 |
Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care |
188 |
125 |
$1K |
| 96127 |
|
672 |
261 |
$1K |
| 3079F |
|
1,233 |
917 |
$872.54 |
| 36415 |
Collection of venous blood by venipuncture |
1,673 |
1,367 |
$602.57 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
598 |
459 |
$570.43 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
105 |
88 |
$528.03 |
| 3078F |
|
1,057 |
753 |
$461.18 |
| 3075F |
|
926 |
696 |
$333.52 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
33 |
28 |
$297.60 |
| 3074F |
|
843 |
595 |
$281.18 |
| 90686 |
|
17 |
15 |
$78.32 |
| 92551 |
|
14 |
13 |
$76.84 |
| 81002 |
|
79 |
59 |
$54.99 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
106 |
72 |
$19.74 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
44 |
39 |
$16.60 |
| 81003 |
|
17 |
14 |
$15.26 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
13 |
12 |
$1.24 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
170 |
146 |
$0.00 |